We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$41.1B
AUM Growth
+$5.37B
Cap. Flow
+$2.44B
Cap. Flow %
5.94%
Top 10 Hldgs %
24.49%
Holding
1,526
New
158
Increased
755
Reduced
338
Closed
110

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$170M
2
TSLA icon
Tesla
TSLA
+$155M
3
NVDA icon
NVIDIA
NVDA
+$116M
4
TSM icon
TSMC
TSM
+$87.6M
5
NTR icon
Nutrien
NTR
+$86.2M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$150M
2
NOC icon
Northrop Grumman
NOC
+$112M
3
HON icon
Honeywell
HON
+$98.1M
4
LIN icon
Linde
LIN
+$87M
5
UBER icon
Uber
UBER
+$72.9M

Sector Composition

Rank Sector Weight
1 Technology 27.6%
2 Healthcare 16.16%
3 Financials 10.71%
4 Consumer Discretionary 9.79%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMND icon
1451
Lemonade
LMND
$4.08B
-14,000
Closed -$933K
LU icon
1452
Lufax Holding
LU
$1.44B
-2,619
Closed -$660K
MAXN
1453
DELISTED
Maxeon Solar Technologies
MAXN
-1,100
Closed -$1.94M
MRSN
1454
DELISTED
Mersana Therapeutics
MRSN
-840
Closed -$195K
MSEX icon
1455
Middlesex Water
MSEX
$1.09B
-517
Closed -$53K
MYRG icon
1456
MYR Group
MYRG
$5.14B
-2,719
Closed -$276K
NEO icon
1457
NeoGenomics
NEO
$2.14B
-50,800
Closed -$2.48M
NKTX icon
1458
Nkarta
NKTX
$176M
-10,500
Closed -$280K
OCFT
1459
DELISTED
OneConnect Financial Technology
OCFT
-711
Closed -$263K
OCUL icon
1460
Ocular Therapeutix
OCUL
$2.03B
-22,900
Closed -$230K
OMER icon
1461
Omeros
OMER
$986M
-14,900
Closed -$197K
ORIC icon
1462
Oric Pharmaceuticals
ORIC
$1.41B
-10,500
Closed -$215K
PAGS icon
1463
PagSeguro Digital
PAGS
$2.54B
-2,400
Closed -$125K
PASG icon
1464
Passage Bio
PASG
$13.9M
-715
Closed -$140K
PLRX icon
1465
Pliant Therapeutics
PLRX
$64.4M
-12,000
Closed -$195K
PSNL icon
1466
Personalis
PSNL
$1.55B
-23,800
Closed -$434K
QNCX icon
1467
Quince Therapeutics
QNCX
$30M
-50
Closed -$933K
RDOG icon
1468
ALPS REIT Dividend Dogs ETF
RDOG
$11.1M
-4,200
Closed -$46K
RGLD icon
1469
Royal Gold
RGLD
$19.8B
-1,100
Closed -$106K
RIGL icon
1470
Rigel Pharmaceuticals
RIGL
$778M
-4,960
Closed -$178K
RLMD icon
1471
Relmada Therapeutics
RLMD
$484M
-5,000
Closed -$127K
RNR icon
1472
RenaissanceRe
RNR
$13.2B
-3,436
Closed -$478K
RYTM icon
1473
Rhythm Pharmaceuticals
RYTM
$7.95B
-12,000
Closed -$157K
SMG icon
1474
ScottsMiracle-Gro
SMG
$3.63B
-2,789
Closed -$415K
STEM icon
1475
Stem
STEM
$50.9M
-16,750
Closed -$7.9M

Similar funds

DekaBank Deutsche Girozentrale's Q4 2021 Portfolio in Review

As of Q4 2021, DekaBank Deutsche Girozentrale held 1,526 positions worth $41.1B, up 15% from $35.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

DekaBank Deutsche Girozentrale deployed $2.44B of net new capital in Q4 2021, opening 158 new positions and adding to 755 existing holdings. Its largest new stake was Regal Rexnord: 103,299 shares worth $17.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Visa, an estimated $150M trimmed.

  • DekaBank Deutsche Girozentrale's largest Q4 2021 buy was Regal Rexnord: 103,299 shares worth $17.6M.
  • DekaBank Deutsche Girozentrale added most to Mastercard in Q4 2021, an estimated $170M increase.
  • DekaBank Deutsche Girozentrale's biggest Q4 2021 reduction was Visa, cutting an estimated $150M.
  • DekaBank Deutsche Girozentrale fully exited Kansas City Southern in Q4 2021, selling an estimated $20.2M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 24% of its $41.1B portfolio in Q4 2021.
  • DekaBank Deutsche Girozentrale opened 158 new positions and closed 110 in Q4 2021.
  • DekaBank Deutsche Girozentrale's portfolio value rose 15% quarter-over-quarter to $41.1B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.